Empowering Pathologists by Bringing Reference Standards to IHC

April 27, 2026

Boston Cell Standards Enters Final Phase of FDA MDDT Program to Qualify First-in-Industry Platform to Standardize Cancer Diagnostic Assays

Continue Reading

January 20, 2026

Boston Cell Standards Calibrator technology presented at The Pathological Society of Great Britain & Ireland Winter Meeting 2026

Continue Reading

January 6, 2026

International study demonstrates the effectiveness of Boston Cell Standards Calibrators for measuring analytical sensitivity used for breast cancer diagnosis.

Continue Reading